Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 22, 2026
Interrupted Systemic Therapy (Drug Holiday) for Metastatic Sarcoma: Is It Safe?
Journal: Current treatment options in oncology
Published: June 15, 2025
A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2025
Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report.
Journal: JTO clinical and research reports
Published: September 06, 2024
Current therapies and future prospective for locally aggressive mesenchymal tumors.
Journal: Frontiers in oncology
Published: February 06, 2023
Much Ado about ASPS: The Rapidly Changing Treatment Paradigms of 2022.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 11, 2022
Current approaches to management of bone sarcoma in adolescent and young adult patients.
Journal: Pediatric blood & cancer
Published: June 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026